0001683168-20-000086.txt : 20200110 0001683168-20-000086.hdr.sgml : 20200110 20200110181129 ACCESSION NUMBER: 0001683168-20-000086 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191230 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: E&Investment, Inc. CENTRAL INDEX KEY: 0001796144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 20522133 BUSINESS ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER STREET 2: B/D 326, TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 00000 BUSINESS PHONE: 82-2-501-3714 MAIL ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER STREET 2: B/D 326, TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: E&Healthcare Investment Fund II CENTRAL INDEX KEY: 0001799534 STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 20522134 BUSINESS ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326 STREET 2: TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 06211 BUSINESS PHONE: 82-2-501-3714 MAIL ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326 STREET 2: TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 06211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: E&Healthcare Investment Fund No.7 CENTRAL INDEX KEY: 0001799532 STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 20522135 BUSINESS ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326 STREET 2: TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 06211 BUSINESS PHONE: 82-2-501-3714 MAIL ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326 STREET 2: TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 06211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 130235 CITY: ANN ARBOR STATE: MI ZIP: 48113 BUSINESS PHONE: 734-245-1700 MAIL ADDRESS: STREET 1: P.O. BOX 130235 CITY: ANN ARBOR STATE: MI ZIP: 48113 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 3/A 1 ownership.xml X0206 3/A 2019-12-30 2020-01-09 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001796144 E&Investment, Inc. C/O NEUROBO PHARMACEUTICALS, INC 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON MA 02115 0 0 1 0 0001799534 E&Healthcare Investment Fund II C/O NEUROBO PHARMACEUTICALS, INC 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON MA 02115 0 0 1 0 0001799532 E&Healthcare Investment Fund No.7 C/O NEUROBO PHARMACEUTICALS, INC 177 HUNTINGTON AVENUE, SUITE 1700 BOSTON MA 02115 0 0 1 0 Common Stock 4335800 I Held by The E&Healthcare Investment Fund II Common Stock 1121190 I Held by The E&Healthcare Investment Fund No. 6 Common Stock 1864799 I Held by The E&Healthcare Investment Fund No. 7 These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund II. These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No. 6 These shares are owned directly by The E&Healthcare Investment Fund No.7, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No.7. E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This Form 3 is being amended to add The E&Healthcare Investment Fund II and The E&Healthcare Investment Fund No.7 as Reporting Persons. /s/ E&Investment, Inc., By: Na Yeon Kim, CEO 2020-01-10 /s/ The E&Healthcare Investment Fund II By: Na Yeon Kim, Representative Director 2020-01-10 /s/ The E&Healthcare Investment Fund No.7 By: Na Yeon Kim, Representative Director 2020-01-10